Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature review.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vasquez-Canizares Natalia, Pain Clare E, Zulian Francesco, Yildiz Amra Adrovic, Appenzeller Simone, Marrani Edoardo, Del Giudice Emanuela, Petaccia Antonella, Tirelli Francesca, Simonini Gabriele, Çakan Mustafa, Cattalini Marco, Julio Paulo Rogerio, Torok Kathryn, Khubchandani Raju, Kasapcopur Ozgur, Robinson Lauren, Al-Abadi Eslam, Gunalp Aybuke, Lu Meiping, Lythgoe Hanna, Robinson Amanda, Sozeri Betul, Shenoi Susan, Willis Emily, Clarke Katherine, Zheng Rongjun, Castaldi Biagio, Leone Valentina, Maniscalco Valerio, Stead Lucy, Ambartsumyan Lusine, Rosser Franziska, Duong Phuoc, Minuti Aurelia, Li Suzanne C, Twilt Marinka, CARRA Juvenile Scleroderma Workgroup
Аннотация
METHODS: A web-based survey was distributed to pediatric rheumatologists to assess cardiopulmonary assessment standard of care practices and immunosuppressive treatment use in JSSc. Respondents were categorized by region (North America, Europe, Latin America, and Asia/Africa), and country income level. A scoping literature review was conducted using the PRISMA-SCR framework to identify outcome measures for six domains in SSc.
RESULTS: One hundred forty-one pediatric rheumatologists from 26 countries completed the survey. Significant variations in JSSc cardiopulmonary assessment practices across regions and income levels were noted. Respondents in North America and Europe reported using pulmonary function tests (PFTs) with diffusing capacity of the lungs for carbon monoxide (DLCO) more frequently than those in Latin America, or Asia/Africa (p < 0.001). The 6-min walk test (6MWT) was used less frequently by respondents in North America than other regions (p = 0.004). Use of oral corticosteroid and cyclophosphamide for treatment of JSSc varies significantly based on country income level, with higher usage in low- and middle-income nations. The scoping review identified 848 relevant articles for data extraction (ranging from 36 to 156 per domain) from a pool of 31,825 records, which were screened in multiple stages by 39 investigators.
CONCLUSION: We found significant variability in JSSc assessment and treatment preferences, influenced by geography and income. This highlights the urgent need for international collaboration and standardized approaches in JSSc care.